ANDE Rapid DNA

ANDE Rapid DNA

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $17.5M

Overview

ANDE Rapid DNA is the global leader in portable, rapid DNA analysis systems for human identification. Founded in 2004 by Dr. Richard Selden, the company pioneered the first FBI-approved system for direct upload to the CODIS database, enabling actionable forensic results at the point of need in less than two hours. Its ruggedized, fully automated technology is deployed in over 25 countries, transforming investigations in law enforcement, disaster response, border security, and the military. ANDE's platform represents a paradigm shift from slow, lab-centric DNA processing to immediate, field-deployable biometric analysis.

DiagnosticsGenetics & Genomics

Technology Platform

Fully automated, portable system for rapid Short Tandem Repeat (STR) DNA analysis. Enables generation of a forensic DNA ID from various sample types in under two hours without a laboratory or technical operator. The platform includes integrated instrumentation, disposable cartridges, and software for analysis and CODIS database upload.

Funding History

2
Total raised:$17.5M
Grant$2.5M
Series A$15M

Opportunities

The global backlog in forensic DNA analysis and the legislative push for faster justice (e.g., The Rapid DNA Act of 2017) create a massive addressable market in law enforcement.
Expansion into adjacent verticals like energy sector security, immigration, and biosurveillance represents significant new revenue streams beyond traditional forensics.

Risk Factors

Primary risks include slow, budget-dependent adoption by government agencies, potential entry of well-funded competitors from the broader life science tools sector, and the ongoing need to prove the technology's efficacy on challenging forensic samples to maintain scientific and legal acceptance in courts.

Competitive Landscape

ANDE is the acknowledged pioneer and current market leader in fully automated, FBI-approved Rapid DNA systems. Competition exists from other companies developing rapid PCR or DNA analysis devices, but ANDE's specific focus on forensic CODIS compliance, rugged portability, and direct database upload creates a strong competitive moat. The landscape may intensify as the market proves its value.